Autophosphorylation of the Tousled-like kinases TLK1 and TLK2 regulates recruitment to damaged chromatin via PCNA interaction
Tousled-like kinases 1 and 2 (TLK1 and 2) are cell cycle-regulated serine/threonine kinases that are involved in multiple biological processes. Mutation of TLK1 and 2 confer neurodegenerative diseases. Recent studies demonstrate that TLK1 and 2 are involved in DNA repair. However, there is no direct evidence that TLK1 and 2 function at DNA damage sites. Here, we show that both TLK1 and TLK2 are hyper-autophosphorylated at their N-termini, at least in part, mediated by their homo- or hetero- dimerization. We found that TLK1 and 2 hyper-autophosphorylation suppresses their recruitment to damaged chromatin. Furthermore, both TLK1 and 2 associate with PCNA specifically through their evolutionarily conserved non-canonical PCNA-interacting protein (PIP) box at the N-terminus, and mutation of the PIP-box abolishes their recruitment to DNA damage sites. Mechanistically, the TLK1 and 2 hyper-autophosphorylation masks the PIP-box and negatively regulates their recruitment to the DNA damage site. Overall, our study dissects the detailed genetic regulation of TLK1 and 2 at damaged chromatin, which provides important insights into their emerging roles in DNA repair.
Authors
- Thuy Nguyen (ORCID: https://orcid.org/0000-0001-7619-4321)
- Kevin D. Raney (ORCID: https://orcid.org/0000-0002-7290-0206)
- Gargi Ghosal (ORCID: https://orcid.org/0000-0001-8399-5354)
- Justin Leung (ORCID: https://orcid.org/0000-0003-4601-390X)
- Kirk L. West (ORCID: https://orcid.org/0000-0002-9894-4549)
- Kyle Tengler
- Natasha Kreiling
Institutions
- The University of Texas at San Antonio Health Science Center (US)
- University of Nebraska Medical Center (US)
- University of Arkansas for Medical Sciences (US)
Publication Details
- Journal
- Nucleic Acids Research
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1093/nar/gkae1279
- Primary Topic
- Genomics and Chromatin Dynamics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Cancer Society
- National Institutes of Health